Christopher C. Coss

2.3k total citations
66 papers, 1.5k citations indexed

About

Christopher C. Coss is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Christopher C. Coss has authored 66 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 21 papers in Genetics and 20 papers in Oncology. Recurrent topics in Christopher C. Coss's work include Estrogen and related hormone effects (21 papers), Hormonal and reproductive studies (15 papers) and Prostate Cancer Treatment and Research (14 papers). Christopher C. Coss is often cited by papers focused on Estrogen and related hormone effects (21 papers), Hormonal and reproductive studies (15 papers) and Prostate Cancer Treatment and Research (14 papers). Christopher C. Coss collaborates with scholars based in United States, Australia and United Kingdom. Christopher C. Coss's co-authors include James T. Dalton, Ramesh Narayanan, Mitch A. Phelps, Duane D. Miller, Amanda Jones, Jeffrey D. Kearbey, Yali He, Casey E. Bohl, Ryan Hard and Agnieszka Martyna and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Christopher C. Coss

59 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Christopher C. Coss United States	20	782	423	332	289	263	66	1.5k
Chihuei Wang Taiwan	21	1.0k 1.3×	380 0.9×	449 1.4×	453 1.6×	244 0.9×	43	1.8k
Fouad K. Habib United Kingdom	26	592 0.8×	458 1.1×	648 2.0×	180 0.6×	320 1.2×	53	1.7k
Karsten Parczyk Germany	18	694 0.9×	163 0.4×	320 1.0×	274 0.9×	447 1.7×	31	1.4k
Krishna Menon United States	28	875 1.1×	181 0.4×	197 0.6×	270 0.9×	344 1.3×	93	2.1k
Donald G. Munroe United States	19	787 1.0×	352 0.8×	76 0.2×	257 0.9×	339 1.3×	33	1.9k
Mark Glover United Kingdom	15	1.3k 1.7×	168 0.4×	265 0.8×	110 0.4×	146 0.6×	23	1.7k
Min‐Wei Chen China	27	1.3k 1.7×	129 0.3×	676 2.0×	163 0.6×	460 1.7×	56	2.4k
Konstantinos Alevizopoulos Greece	20	1.0k 1.3×	104 0.2×	150 0.5×	238 0.8×	545 2.1×	31	1.6k
Bunzo Sato Japan	25	1.2k 1.6×	633 1.5×	226 0.7×	642 2.2×	265 1.0×	114	2.3k
Francis Vacherot France	29	1.1k 1.5×	208 0.5×	1.2k 3.7×	178 0.6×	349 1.3×	73	2.5k

Countries citing papers authored by Christopher C. Coss

Since Specialization

Citations

This map shows the geographic impact of Christopher C. Coss's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher C. Coss with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher C. Coss more than expected).

Fields of papers citing papers by Christopher C. Coss

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher C. Coss. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher C. Coss. The network helps show where Christopher C. Coss may publish in the future.

Co-authorship network of co-authors of Christopher C. Coss

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher C. Coss. A scholar is included among the top collaborators of Christopher C. Coss based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher C. Coss. Christopher C. Coss is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Vu, Trang T., Justin Thomas, Zhiliang Xie, et al.. (2025). Intramuscular CMT‐167 Tumours Produce a Mild Cachexia Phenotype in C57BL/6J Mice. PubMed. 8(1).

Yang, Dexi, et al.. (2024). Merging Natural Product Structures with Pharmaceutical Leads: Unnatural Enantiomers of Estranes as Glucocorticoid Receptor Modulators That Suppress TNF-α and IL-6 Release. Journal of Medicinal Chemistry. 67(18). 16185–16194. 1 indexed citations

Xing, Enming, Anees M. Dauki, Hanna S. Radomska, et al.. (2023). SAT021 Development Of Niclosamide Analogs For Treatment Of Androgen Receptor Positive Hepatocellular Carcinoma. Journal of the Endocrine Society. 7(Supplement_1). 1 indexed citations

Guo, Yizhen, Justin Thomas, Samuel K. Kulp, et al.. (2023). Antibody Drug Clearance: An Underexplored Marker of Outcomes with Checkpoint Inhibitors. Clinical Cancer Research. 30(5). 942–958. 6 indexed citations

Bazioli, Jaqueline Moraes, Daniel D. Lantvit, Samuel K. Kulp, et al.. (2023). Exploration of Verticillins in High-Grade Serous Ovarian Cancer and Evaluation of Multiple Formulations in Preclinical In Vitro and In Vivo Models. Molecular Pharmaceutics. 20(6). 3049–3059. 3 indexed citations

Gumpper, Kristyn, Phil A. Hart, Martha A. Belury, et al.. (2022). Altered Plasma Fatty Acid Abundance Is Associated with Cachexia in Treatment-Naïve Pancreatic Cancer. Cells. 11(5). 910–910. 7 indexed citations

Aldrich, Leslie N., Joanna E. Burdette, Esperanza J. Carcache de Blanco, et al.. (2022). Discovery of Anticancer Agents of Diverse Natural Origin. Journal of Natural Products. 85(3). 702–719. 30 indexed citations

Sedlák, David, Werner Tjarks, Hanna S. Radomska, et al.. (2021). Structure–Activity Relationship of para-Carborane Selective Estrogen Receptor β Agonists. Journal of Medicinal Chemistry. 64(13). 9330–9353. 18 indexed citations

Collier, Katharine A., Herbert B. Newton, Erinn M. Hade, et al.. (2021). A phase 1 trial of the histone deacetylase inhibitor AR-42 in patients with neurofibromatosis type 2-associated tumors and advanced solid malignancies. Cancer Chemotherapy and Pharmacology. 87(5). 599–611. 20 indexed citations

10.

Thomas‐Ahner, Jennifer M., Samuel K. Kulp, Moray J. Campbell, et al.. (2021). Inhibition of androgen/AR signaling inhibits diethylnitrosamine (DEN) induced tumour initiation and remodels liver immune cell networks. Scientific Reports. 11(1). 3646–3646. 10 indexed citations

11.

Dauki, Anees M., James S. Blachly, Esko A. Kautto, et al.. (2019). Transcriptionally Active Androgen Receptor Splice Variants Promote Hepatocellular Carcinoma Progression. Cancer Research. 80(3). 561–575. 29 indexed citations

12.

Young, Alexandria N., Daniel D. Lantvit, Christopher C. Coss, et al.. (2018). Phyllanthusmin Derivatives Induce Apoptosis and Reduce Tumor Burden in High-Grade Serous Ovarian Cancer by Late-Stage Autophagy Inhibition. Molecular Cancer Therapeutics. 17(10). 2123–2135. 29 indexed citations

13.

Ponnusamy, Suriyan, Christopher C. Coss, Thirumagal Thiyagarajan, et al.. (2017). Novel Selective Agents for the Degradation of Androgen Receptor Variants to Treat Castration-Resistant Prostate Cancer. Cancer Research. 77(22). 6282–6298. 70 indexed citations

14.

Narayanan, Ramesh, Christopher C. Coss, & James T. Dalton. (2017). Development of selective androgen receptor modulators (SARMs). Molecular and Cellular Endocrinology. 465. 134–142. 169 indexed citations

15.

Cheng, Hao, Zhiliang Xie, W.P. Jones, et al.. (2016). Preclinical Pharmacokinetics Study of R- and S-Enantiomers of the Histone Deacetylase Inhibitor, AR-42 (NSC 731438), in Rodents. The AAPS Journal. 18(3). 737–745. 12 indexed citations

16.

Harrington, Bonnie K., Heather L. Gardner, Raquel Izumi, et al.. (2016). Preclinical Evaluation of the Novel BTK Inhibitor Acalabrutinib in Canine Models of B-Cell Non-Hodgkin Lymphoma. PLoS ONE. 11(7). e0159607–e0159607. 43 indexed citations

17.

Yu, Evan Y., Robert H. Getzenberg, Christopher C. Coss, et al.. (2014). Selective Estrogen Receptor Alpha Agonist GTx-758 Decreases Testosterone with Reduced Side Effects of Androgen Deprivation Therapy in Men with Advanced Prostate Cancer. European Urology. 67(2). 334–341. 16 indexed citations

18.

Kim, Ju‐Hyun, Christopher C. Coss, & James T. Dalton. (2013). Effect of para halogen modification of S-3-(phenoxy)-2-hydroxy-2-methyl-N-(4-nitro-3-trifluoromethyl-phenyl)-propionamides on metabolism and clearance. Archives of Pharmacal Research. 37(11). 1464–1476. 2 indexed citations

19.

Liang, Sheng-Ben, Young Trieu, Zhihua Li, et al.. (2011). Molecular Target Characterization and Antimyeloma Activity of the Novel, Insulin-like Growth Factor 1 Receptor Inhibitor, GTx-134. Clinical Cancer Research. 17(14). 4693–4704. 8 indexed citations

20.

Coss, Christopher C., Casey E. Bohl, & James T. Dalton. (2011). Cancer cachexia therapy: a key weapon in the fight against cancer. Current Opinion in Clinical Nutrition & Metabolic Care. 14(3). 268–273. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact